(1)
Ueda, Y.; Ishii, H.; Kitano, T.; Shindo, M.; Miyazawa, H.; Ito, K.; Hirai, K.; Kaku, Y.; Mori, H.; Hoshino, T.; Ookawara, S.; Kakei, M.; Tabei, K.; Morishita, Y. Effects and Safety of Linagliptin As an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers. dti 2016, 10.